Halozyme Therapeutics Inc HALO:NASDAQ

Last Price$44.48NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.48(1.09%)
Bid (Size)$42.10 (3)
Ask (Size)$46.85 (8)
Day Low / High$43.46 - 44.64
Volume1.1 M

View Biotechnology IndustryPeer Comparison as of 07/01/2022


Halozyme Therapeutics Inc ( NASDAQ )

Price: $44.48
Change: +0.48 (1.09%)
Volume: 1.1 M
4:00PM ET 7/01/2022

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Exelixis Inc ( NASDAQ )

Price: $21.57
Change: +0.75 (3.60%)
Volume: 2.1 M
4:00PM ET 7/01/2022

Exact Sciences Corp ( NASDAQ )

Price: $41.13
Change: +1.74 (4.42%)
Volume: 1.5 M
4:00PM ET 7/01/2022

Novavax Inc ( NASDAQ )

Price: $57.15
Change: +5.72 (11.12%)
Volume: 6.4 M
4:00PM ET 7/01/2022

Read more news Recent News

--Berenberg Bank Suspends Coverage of 25 Companies in Consumer Discretionary, Healthcare, Industrial Tech, and Software Sectors
8:40AM ET 7/01/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Halozyme Therapeutics Launches Testosterone Replacement Therapy Drug Tlando
10:49AM ET 6/07/2022 MT Newswires

Halozyme Therapeutics (HALO) said Tuesday it has commercially launched Tlando, an oral treatment for testosterone replacement therapy in adult males for...

Goldman Sachs Raises Halozyme Therapeutics' Price Target to $60 From $48, Buy Rating Kept
10:37AM ET 5/26/2022 MT Newswires

Halozyme Therapeutics (HALO) has an average rating of outperform and price targets ranging from $19 to $62, according to analysts polled by Capital IQ. (MT...

Halozyme Says Antitrust Act Waiting Period Expires for Antares Pharma Acquisition
9:47AM ET 5/12/2022 MT Newswires

Halozyme Therapeutics (HALO) said Thursday the waiting period under the Hart-Scott-Rodino antitrust act for its planned acquisition of Antares Pharma has...

Company Profile

Business Description
Number of Employees281
Recent SEC Filing05/24/2022SC TO-T/A

Company Highlights

Price Open$44.03
Previous Close$44.00
52 Week Range$31.36 - 48.58
Market Capitalization$6.1 B
Shares Outstanding137.9 M
SectorHealth Technology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings14.88
Earnings per Share$2.98
Beta vs. S&P 500N/A
Revenue$151.9 M
Net Profit Margin92.23%
Return on Equity202.61%

Analyst Ratings as of 06/30/2022

Consensus RecommendationConsensus Icon
Powered by Factset